GlassScriptPhysician profile
Rodolfo A Munera
NPI 1154382760
$5,114.89
in general payments reported to CMS, 2019-2025
37 companies · $955 in 2025
The $955 reported for 2025 was more than what 78% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $443 · 2020: $270 · 2021: $838 · 2022: $860 · 2023: $822 · 2024: $927 · 2025: $955.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,634 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $53.00 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,633.98 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $53.00 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,757.24 | 2019-2025 | Biktarvy |
| Viiv Healthcare Company | $720.87 | 2019-2025 | Apretude, Dovato, Cabenuva |
| Glaxosmithkline, LLC. | $238.75 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Becton, Dickinson and Company | $208.00 | 2022-2024 | Site-Rite |
| Astrazeneca Pharmaceuticals LP | $184.36 | 2019-2025 | Airsupra, Farxiga |
| Amgen INC. | $172.11 | 2019-2024 | Otezla, Repatha, Evenity |
| Lilly USA, LLC | $170.21 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Janssen Biotech, INC. | $154.63 | 2019-2023 | Symtuza |
| Emd Serono, INC. | $141.89 | 2020-2024 | Serostim, Serostim |
| Insmed, INC. | $141.57 | 2023-2025 | Arikayce |
| Amarin Pharma, INC. | $123.85 | 2019-2022 | |
| Exact Sciences Corporation | $107.37 | 2023-2024 | Cologuard Collection Kit |
| Dexcom, INC. | $101.52 | 2021-2024 | Dexcom G6 Transmitter |
| Medtronic, INC. | $88.96 | 2022 | |
| Janssen Products, LP | $85.00 | 2021 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodolfo Munera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.